Posted by NPRA1985 > 2020-12-09 15:20 | Report Abuse

UAE says Sinopharm vaccine has 86% efficacy against COVID-19

DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.

The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.

The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.

“The analysis shows no serious safety concerns,” it said.

It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.

https://www.reuters.com/article/health-coronavirus-emirates/update-1-uae-says-sinopharm-vaccine-has-86-efficacy-against-covid-19-idUSL1N2IP09V

Posted by NPRA1985 > 2020-12-09 22:25 | Report Abuse

United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19

TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.

The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.

The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.

The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”

The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.

https://www.forbes.com/sites/roberthart/2020/12/09/united-arab-emirates-claims-chinas-sinopharm-vaccine-is-100-effective-at-preventing-moderate-and-severe-covid-19/?sh=2a60fb42595c

Posted by NPRA1985 > 2020-12-10 23:56 | Report Abuse

Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing.

“The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people.

“Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed.

SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there.

https://asiatimes.com/2020/12/uae-gives-chinese-vaccines-a-shot-in-the-arm/

Posted by NPRA1985 > 2020-12-12 17:36 | Report Abuse

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Posted by NPRA1985 > 2020-12-13 17:31 | Report Abuse

Bahrain Approves China’s Sinopharm Covid-19 Vaccine

Bahrain approved the registration of the Sinopharm Group Co Ltd. vaccine against the coronavirus, about a week after the United Arab Emirates registered the Chinese-made vaccine.

“Results from Phase III clinical trials showed an 86% efficacy rate, a 99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of Covid-19,” the National Health Regulatory Authority said in a statement Sunday.

Bahrain has participated in phase III clinical trials, in which more than 7,700 volunteers signed up. Bahrain had previously authorized the emergency use of the vaccine, which was provided to frontline workers in contact with coronavirus patients.

The UAE registered the Sinopharm vaccine after finding it had a 86% efficacy rate, paving the way for a full public use and allowing for a re-opening of the Gulf nation’s economy.

Egypt plans to start the process of inoculation against the coronavirus after receiving the first shipments of Sinopharm vaccine.

https://www.bloomberg.com/news/articles/2020-12-13/bahrain-approves-china-s-sinopharm-covid-19-vaccine

https://abcnews.go.com/Health/wireStory/bahrain-approves-chinese-covid-19-vaccine-74699175

Posted by NPRA1985 > 2020-12-13 18:14 | Report Abuse

Govt to increase Covid-19 vaccine purchase to cover 60%-70% of M'sians — PM

The government has plans to increase its purchase of the Covid-19 vaccine to cover the immunisation needs of about 60%-70% of Malaysians compared with 30% currently.

Prime Minister Tan Sri Muhyiddin Yassin said this was because some nations had purchased doses exceeding their population.

“As for Malaysia, we have already got 30%. I have instructed Health Minister Datuk Seri Dr Adham Baba along with [Science, Technology and Innovation Minister] Khairy Jamaluddin Abu Bakar to negotiate and increase it from 30% to 60% or 70%.

https://www.theedgemarkets.com/article/govt-mulls-increasing-covid19-vaccine-purchase-30-6070-meet-msians-immunisation-needs-%E2%80%94-pm

Posted by RainT > 2021-02-19 18:11 | Report Abuse

consecutive 2 qtr profit & margin drop

Posted by RainT > 2021-02-19 18:12 | Report Abuse

KOTRA have touch any vaccine biz?

think is no relate at all

Posted by MF0001 > 2021-03-25 15:52 | Report Abuse

KOTRA COME TO PAPA

DROP TO PAPA

1.850 PLZZZZZZZZZZZZZZZZZZZZZZZZZZZZZ

:DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

Posted by risktoreward > 2021-07-19 12:11 | Report Abuse

2.36 beli

Posted by risktoreward > 2021-07-23 16:22 | Report Abuse

have to sacrifice this baby, let go at 2.30

Posted by ValueMe > 2021-08-24 16:57 | Report Abuse

Yummy

Posted by wallstreetrookie > 2021-09-01 09:14 | Report Abuse

Looks like another gapper/limit up stock

Posted by ValueMe > 2021-09-01 11:00 | Report Abuse

Today traders buy tomorrow they sell.Only happens in KLSE.Just shows the level of confidence among investors and traders :D

Posted by holihom > 2021-09-01 11:40 | Report Abuse

what happen? 3.13 now

Posted by wazhab > 2021-09-01 12:05 | Report Abuse

Good profit

Posted by wallstreetrookie > 2021-09-01 12:10 | Report Abuse

Under the radar pharmaceutical company. Similar to YSPSAH, Apex Healthcare

Posted by wallstreetrookie > 2021-09-01 12:10 | Report Abuse

No price target because the market cap is too small

Posted by wallstreetrookie > 2021-09-01 12:13 | Report Abuse

This is the best company for M&A if this company is listed in other markets lol

Posted by wallstreetrookie > 2021-09-01 12:13 | Report Abuse

Tomorrow another round of limit-up for sure. Such a hidden gem

Posted by ValueMe > 2021-09-01 12:18 | Report Abuse

Sell off before con yy starts promoting this stock. 30 percent in 1 week.Yummy Yummy.

Posted by troy88 > 2021-09-01 12:18 | Report Abuse

Well done. Another round of big gains tomorrow..

Posted by yang88 > 2021-09-01 12:47 | Report Abuse

Congratulations to those long term investors..

Posted by Primeinvestor > 2021-09-01 16:17 | Report Abuse

superb results, no wonder limit up, how can it achieved such a good profit

Posted by yang88 > 2021-09-01 18:22 | Report Abuse

Yaloh, Revenue 43+m, profit 14m, profit margin 28%, incredible......how do they achieve??

Posted by KingEdwardIIX > 2021-09-01 19:41 | Report Abuse

nowsday..ppl pump n dump...carefull..

Posted by sadforvivo > 2021-09-03 19:20 | Report Abuse

KingEdwardIIX agree with you. if want to trade, better set CL level.

Posted by clouud1234 > 2021-09-08 09:53 |

Post removed.Why?

Posted by wallstreetrookie > 2021-09-30 12:45 | Report Abuse

Add more

Posted by wallstreetrookie > 2021-10-07 08:18 | Report Abuse

Kotra Industries Maintain Overweight

Posted by wallstreetrookie > 2021-10-17 17:22 | Report Abuse

Buy the dip

Posted by wallstreetrookie > 2021-10-17 17:22 | Report Abuse

Stocks to watch in Q1 2022

Posted by wallstreetrookie > 2021-10-26 16:20 | Report Abuse

Add

Posted by treasurehunt > 2021-11-30 16:15 | Report Abuse

One day show?

Posted by Keeheong1960 > 2021-12-08 10:13 | Report Abuse

A good share move up slowly.

Posted by treasurehunt > 2021-12-09 17:47 | Report Abuse

No more story? Nova performance is good as well.

Posted by ipohwhitecoffee > 2021-12-13 11:37 | Report Abuse

Good QR growth. Must DCA in portfolio. Despite low volume lol

Posted by wallstreetrookie > 2021-12-13 11:41 | Report Abuse

@ipohwhitecoffee
It is the only self-sustainable pharmaceutical company on Bursa. Very low risk compared to MGRC lolllll haha

Posted by wallstreetrookie > 2021-12-13 11:41 | Report Abuse

MGRC is high-risk bio tech firm. Kotra is boomer old fashioned Pharma bio tech company

Posted by wallstreetrookie > 2021-12-27 12:01 | Report Abuse

2021 Q4 Revenue Breakdown

70.5% Malaysia
29.5% Other Countries APAC

Excess Cash: 68.7 M
P/FCF - 6.96
EV/EBITDA - 5.37

Posted by wallstreetrookie > 2021-12-27 12:02 | Report Abuse

Biotech companies always outperform during economic recession

Posted by treasurehunt > 2021-12-27 12:11 | Report Abuse

Kotra liquidity is rather low. Gross Margin has surged more than double digit for the last 2 quarters. It's quite similar with Nova. But Nova fetchs at much higher multiple PER.

Posted by wallstreetrookie > 2021-12-27 13:10 | Report Abuse

Both are very different industries. Do more research

Posted by treasurehunt > 2021-12-27 13:15 | Report Abuse

Kotra has started its capex in last FY. Majority of the capex will be incurred in FY2022.

AGM minutes 2020
For FY2021, the Group’s capital expenditure to upgrade manufacturing
equipment, including cost of expansion of warehouse, is RM57 million. A
major portion of the cost may be incurred mainly in FY2022.

Posted by wallstreetrookie > 2021-12-27 15:37 | Report Abuse

Those are forward-looking statement that no one cares

Posted by wallstreetrookie > 2021-12-27 15:38 | Report Abuse

KTRI MK FA <GO>

Easy

Posted by ipohwhitecoffee > 2021-12-31 16:43 | Report Abuse

Boring, but solid. Not much noises also

Posted by tales029 > 2022-01-13 21:08 | Report Abuse

break out already

Posted by treasurehunt > 2022-01-14 16:41 | Report Abuse

Cool!

Posted by wallstreetrookie > 2022-01-31 05:47 | Report Abuse

An MSCI gauge of Southeast Asian, or Asean, equities fell less than 2% this week and rose to an 18-month high relative to the Asia benchmark, which slumped almost 5%.

“Asean is now less vulnerable than in the past as current account balances have improved and valuations on equities, bonds and currencies are less demanding,” UBS Group AG strategists including Niall MacLeod wrote in a note Thursday. “Markets are in a much better position relative to 2013.”

Bloomberg | Markets